Contact
searchSearch
HMP Global

Skin of Color Topic Center

Featured

Nada Elbuluk
Podcasts
Inflammatory Skin Conditions in Skin of Color
01/22/2025
Nada Elbuluk, MD, MSc
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the...
01/22/2025
The Dermatologist
SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
Janiene Luke, MD
Videos
Insights on Skin of Color: Pigmentary Disorders
01/28/2022
Janiene Luke, MD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society...
01/28/2022
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
DR
Videos
Notable Results From the Trials of Ruxolitinib Cream for Vitiligo
01/14/2022
David Rosmarin, MD
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights...
01/14/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Recognizing the Impact of Diseases in Skin of Color
07/16/2021
Lauren Mateja
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker...
07/16/2021
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist

Expert Insights

Nada Elbuluk
Podcasts
Inflammatory Skin Conditions in Skin of Color
01/22/2025
Nada Elbuluk, MD, MSc
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the...
01/22/2025
The Dermatologist
Janiene Luke, MD
Videos
Insights on Skin of Color: Pigmentary Disorders
01/28/2022
Janiene Luke, MD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society...
01/28/2022
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
DR
Videos
Notable Results From the Trials of Ruxolitinib Cream for Vitiligo
01/14/2022
David Rosmarin, MD
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights...
01/14/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Recognizing the Impact of Diseases in Skin of Color
07/16/2021
Lauren Mateja
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker...
07/16/2021
The Dermatologist
Dr Seemal R. Desai on The Skin Bleaching Epidemic
Q&As
Dr Seemal R. Desai on The Skin Bleaching Epidemic
04/25/2021
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
During the What’s New in Skin of...
04/25/2021
The Dermatologist
Tackling Racism in Dermatology: From Literature to Practice
Feature Story
Tackling Racism in Dermatology: From Literature to Practice
11/16/2020
Lauren Mateja
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know...
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know...
The...
11/16/2020
The Dermatologist
Seeing the Spectrum: Including and Embracing Skin of Color Education in Everyday Dermatologic Practice
Cover Story
Seeing the Spectrum: Including and Embracing Skin of Color Education in Everyday Dermatologic Practice
08/13/2020
Taylor Jamerson
Recent anti-racism movements have accentuated the longstanding need for increased training on darker skin types. The Skin of Color Society and its members are making strides in helping all dermatologists improve their knowledge.
Recent anti-racism movements have accentuated the longstanding need for increased training on darker skin types. The Skin of Color Society and its members are making strides in helping all dermatologists improve their knowledge.
Recent anti-racism movements...
08/13/2020
The Dermatologist
Developing a Care Program for Neglected Patient Groups: Oculocutaneous Albinism
Feature Story
Developing a Care Program for Neglected Patient Groups: Oculocutaneous Albinism
06/11/2020
Ellen Anshelevich, BA; Victoria Williams, MD
Oculocutaneous albinism (OCA) is a rare genetic disorder that all physicians learn about in medical school, but it may never again cross your mind as a practicing dermatologist in the United States. However, in...
Oculocutaneous albinism (OCA) is a rare genetic disorder that all physicians learn about in medical school, but it may never again cross your mind as a practicing dermatologist in the United States. However, in...
...
06/11/2020
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
HSF-Reviewed Features
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
09/08/2025
Gretchen M. Roth, MD, FAAD; Precious A. Anyanwu
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve...
09/08/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna. Learn practical clinical strategies, safety...
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
Cover Story
Type 2 Inflammation in Atopic Dermatitis
08/02/2025
Mona Shahriari, MD, FAAD
Join Dr Mona Shahriari for a high-level primer on how type 2 immune dysregulation drives this disease.
Join Dr Mona Shahriari for a high-level primer on how type 2 immune dysregulation drives this disease.
Join Dr Mona Shahriari for a...
08/02/2025
The Dermatologist
Feature Story
GLP-1 Agonists: Implications for Dermatology
08/02/2025
Serene Majid, BA; Steven R. Feldman, MD, PhD
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an...
08/02/2025
The Dermatologist

News

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use